$357 Million is the total value of DILLON & ASSOCIATES INC's 68 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Exit | Celgene | $0 | – | -2,659 | -100.0% | -0.08% | – |
| CTSH | Exit | Cognizant Tech Sol CL A | $0 | – | -5,923 | -100.0% | -0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Apple, Inc. | 45 | Q2 2024 | 11.9% |
| Stryker | 45 | Q2 2024 | 6.3% |
| Visa Inc. | 45 | Q2 2024 | 6.5% |
| Abbott Labs | 45 | Q2 2024 | 5.7% |
| Automatic Data Processing | 45 | Q2 2024 | 4.8% |
| PepsiCo | 45 | Q2 2024 | 4.9% |
| Air Products | 45 | Q2 2024 | 3.7% |
| Paychex | 45 | Q2 2024 | 4.3% |
| Colgate-Palmolive | 45 | Q2 2024 | 5.9% |
| Novo-Nordisk ADR | 45 | Q2 2024 | 5.9% |
View DILLON & ASSOCIATES INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-06 |
| 13F-HR | 2024-04-30 |
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR/A | 2023-05-02 |
| 13F-HR | 2023-05-01 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-07-26 |
View DILLON & ASSOCIATES INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.